Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE trial of short-term rivaroxaban after transradial coronary angiography or PCI
ChiCTR1900026974Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rivaroxaban in Radial artery occlusion (RAO) and Radial artery stenosis (RAS) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Right radial artery occlusion. Planned start May 2020; status: not yet recruiting.
02
Drugs
rivaroxaban
03
Conditions
Radial artery occlusion (RAO)Radial artery stenosis (RAS)
Beyond the preview
Go deeper on ChiCTR1900026974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026974.